ATE109793T1 - Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. - Google Patents

Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.

Info

Publication number
ATE109793T1
ATE109793T1 AT88304551T AT88304551T ATE109793T1 AT E109793 T1 ATE109793 T1 AT E109793T1 AT 88304551 T AT88304551 T AT 88304551T AT 88304551 T AT88304551 T AT 88304551T AT E109793 T1 ATE109793 T1 AT E109793T1
Authority
AT
Austria
Prior art keywords
linear
alpha
analogues
cyclic analogues
extraordinary effects
Prior art date
Application number
AT88304551T
Other languages
English (en)
Inventor
Victor J Hruby
Fahad A Al-Obeidi
Mac E Hadley
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Application granted granted Critical
Publication of ATE109793T1 publication Critical patent/ATE109793T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88304551T 1987-05-22 1988-05-19 Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. ATE109793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
CA000578920A CA1340107C (en) 1987-05-22 1988-09-30 Linear and cyclic analoques of alpha-msh fragments with extraordinary potency

Publications (1)

Publication Number Publication Date
ATE109793T1 true ATE109793T1 (de) 1994-08-15

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88304551T ATE109793T1 (de) 1987-05-22 1988-05-19 Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.

Country Status (11)

Country Link
EP (1) EP0292291B1 (de)
JP (1) JPH0826077B2 (de)
CN (1) CN1031242C (de)
AT (1) ATE109793T1 (de)
CA (1) CA1340107C (de)
DE (1) DE3851002T2 (de)
DK (1) DK172760B1 (de)
FI (1) FI882380A7 (de)
IE (1) IE64903B1 (de)
PH (1) PH25819A (de)
PT (1) PT87560B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
EP0389950A1 (de) * 1989-03-23 1990-10-03 Lion Corporation Inhibitor des melanocytenstimulierenden Hormons und dieses enthaltendes, äusserlich anwendbares Präparat
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
DE69429768T2 (de) * 1993-04-05 2002-09-19 Competitive Technologies, Inc. Diagnose und behandlung von erektilen funktionsstörungen
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5420109A (en) 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
ATE393783T1 (de) 1999-03-29 2008-05-15 Procter & Gamble Melanocortinrezeptor-liganden
TW200716979A (en) * 1999-06-29 2007-05-01 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
CN101497654A (zh) 2003-09-30 2009-08-05 诺沃挪第克公司 黑皮素受体激动剂
JP5449673B2 (ja) * 2004-10-08 2014-03-19 クリヌベール、ファーマスーティカルズ、リミテッド 対象者におけるメラニン形成を誘導するための組成物および方法
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α-黑素细胞刺激素类似物及其用途
AU2006269321A1 (en) 2005-07-08 2007-01-18 Ipsen Pharma S.A.S. Ligands of melanocortin receptors
US20110130705A1 (en) 2008-03-27 2011-06-02 Clinuvel Pharmaceuticals Limited Therapy for vitiligo
JP5628796B2 (ja) 2008-06-09 2014-11-19 パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. 性的不能の治療用のメラノコルチンレセプタ特異的ペプチド
EP2350031A2 (de) 2008-08-20 2011-08-03 Ensemble Therapeutics Corporation Makrocyclische verbindungen zur inhibierung des tumornekrosefaktors alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
EA201290295A1 (ru) 2009-11-23 2013-01-30 Палатин Текнолоджиз, Инк. Специфичные к рецептору меланокортина-1 линейные пептиды
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
EP2970388B1 (de) * 2013-03-15 2018-07-25 Rhythm Pharmaceuticals, Inc. Peptidzusammensetzungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
AU1650688A (en) 1988-11-24
PT87560A (pt) 1989-05-31
EP0292291B1 (de) 1994-08-10
JPH0826077B2 (ja) 1996-03-13
CN1031242C (zh) 1996-03-13
DK277788A (da) 1988-11-23
DK277788D0 (da) 1988-05-20
CN1032795A (zh) 1989-05-10
EP0292291A2 (de) 1988-11-23
CA1340107C (en) 1998-10-27
IE881537L (en) 1988-11-22
PT87560B (pt) 1992-09-30
DK172760B1 (da) 1999-06-28
DE3851002D1 (de) 1994-09-15
AU618733B2 (en) 1992-01-09
FI882380A7 (fi) 1988-11-23
PH25819A (en) 1991-11-05
JPS6470499A (en) 1989-03-15
DE3851002T2 (de) 1995-02-02
FI882380A0 (fi) 1988-05-20
EP0292291A3 (en) 1990-05-02
IE64903B1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
ATE109793T1 (de) Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.
DE68929551D1 (de) Menschliche DNase
DE3752364D1 (de) Osteoinduktive Zusammensetzungen
FR2712286B1 (fr) Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
DE69201564D1 (de) Verwendung von metalloxidmanopigmenten zum schutz von haarkeratin vor äusseren einflüssen, insbesondere sonnenlicht, verfahren zum schutz des haares und gelzusammensetzung unter verwendung dieser nanopigmente.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
NO844579L (no) Enzymresistente immunomodulerende peptider.
ATE119915T1 (de) Dns-sequenzen, rekombinante dns-moleküle und verfahren zur herstellung von ''mullerian inhibiting substance''-ähnlichen polypeptiden.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE69230798D1 (de) Rekombinante immuntoxine
ATE86488T1 (de) Verwendung von minoxidil zur wundheilung.
EP0656791A4 (de) Therapeutische zusammensetzungen und verfahren unter verwendung von pqq.
ES2177625T3 (es) Citoquina cc-1 humana circulante.
NO890046L (no) Disubstituerte pyridiner.
DE69012870D1 (de) Gateelektrodenimpulsgenerator zur statischen Var-Kompensation.
ATE76579T1 (de) Interferon-zusammensetzungen.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
IT1208760B (it) Trattamento delle malattie infiammatorie articolari
ATE87314T1 (de) Platin-arzneimittel.
ES551053A0 (es) Perfeccionamientos en el metodo de tratamiento de simil-cuero y cuero
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
DE3884407D1 (de) Trifluormethyl-1-tetralinabkömmlinge, deren herstellung und verwendung bei der herstellung von verbindungen mit therapeutischer wirkung.
FI880801A7 (fi) Puun käsittelyyn tarkoitetut koostumukset ja menetelmät puun käsittelemiseksi.